Industry Research Reports

Home > Reports > Service & Software > Global Microphysiological System Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Global Microphysiological System Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Industry: Service & Software

Published Date: 2025-10-13

Pages: 121 Pages

Report ld: 4932390

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Industry Insights:

Microphysiological System Research:CAGR of 19.6% during the forecast period

Microphysiological System Market Size(US$)

CAGR 2025-2031

16.2%

Market Size,2031

USD 370

Million

Market Snapshot

Market Size in 2025 (Value)

US$ 150 million

Market Forecast in 2031(Value)

US$ 370 million

CAGR

16.2%

Years Considered

2020-2031

Base Year

2025

Forecast Period

2025-2031

Source: Secondary research, interviews with experts, and QYResearch analysis

The global Microphysiological System market size was US$ 126 million in 2024 and is forecast to a readjusted size of US$ 370 million by 2031 with a CAGR of 16.2% during the forecast period 2025-2031.

Microphysiological Systems (MPS) are in vitro models composed of cells, tissue explants, or stem-cell derived 'organoid' formations of human or animal origin. These models provide translational biochemical, electrical, and/or physiomechanical responses to represent organ and tissue function, with great potential to replace some animals used in research. According to the U.S. Food and Drug Administration (FDA), MPS model "functional features of a specific tissue or organ of human or animal origin by exposing cells to a microenvironment that mimics the physiological aspects important for their function or pathophysiological condition." These systems are being developed to better mimic some aspects of specific organ systems or combinations of organ systems to improve upon standard two-dimensional (2D) cell systems, with the goal of eventually replacing animal models being used for hazard identification, risk assessment, and disease modeling, among other uses.

The global key companies of Microphysiological System include Emulate, Mimetas, InSphero, TissUse, CN Bio, Valo Health (TARA Biosystems), Hesperos, TNO, 28bio, Newcells Biotech, etc. In 2024, the global five largest players hold a share approximately 48.81% in terms of revenue.

Due to better policy and financial support in European countries and USA and earlier research, the overall industry of microphysiological system has developed rapidly, and the industrialization process in other regions such as Asia is lagging behind.

It is worth noting that because the microphysiological system industry is still in the early stages of development, and the mid-stream and downstream demand has not yet increased, many microphysiological system companies play an upstream role to some extent and mostly conduct organoid and organ-on-chip research on their own. Research and development of chip automation, high-throughput operating instruments and imaging equipment.

With the further development of the industry in the future and the implementation of relevant policies and standards, the industry's demand for upstream will increase, which will promote the birth of more professional upstream companies and the business transformation of some microphysiological system companies.

The global Microphysiological System market is strategically segmented by company, region (country), by Type, and by End User. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by End User for 2020-2031.

MARKET SEGMENTATION

By Company

Emulate
Mimetas
TissUse
InSphero
Hesperos
CN Bio
TNO
28bio
Beijing Daxiang Biotech
Newcells Biotech
Nortis (Quris-Al)
Valo Health (TARA Biosystems)
Altis Biosystems
Draper Laboratory
Netri
Bi/ond
ImmuONE
AlveoliX
Cherry Biotech
Ananda Devices
Obatala Sciences
BiomimX
React4life
Aracari Bio
StemPharm
SynVivo

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Human Organ and Tissue Models
Disease Models
Non-Human Species Models

Segment by Application

Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Others

biaoTi CHAPTER OUTLINE

Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).

Chapter 2: Quantitative analysis of Microphysiological System market size and growth potential at global, regional, and country levels.

Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).

Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Disease Models in China).

Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Academic & Research Institutes in India).

Chapter 6: Regional revenue breakdown by company, type, application and customer.

Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.

Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.

Chapter 9: Actionable conclusions and strategic recommendations.

WHY THIS REPORT

Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Microphysiological System value chain, addressing:

- Market entry risks/opportunities by region

- Product mix optimization based on local practices

- Competitor tactics in fragmented vs. consolidated markets

biaoTi QYRESEARCH'S STRENGTHS

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Report Overview

1.1 Study Scope

1.2 Market by Type

1.2.1 Global Market Size Growth by Type: 2020 VS 2024 VS 2031

1.2.2 Human Organ and Tissue Models

1.2.3 Disease Models

1.2.4 Non-Human Species Models

1.3 Market by End User

1.3.1 Global Market Share by End User: 2020 VS 2024 VS 2031

1.3.2 Pharmaceutical & Biotechnology Companies

1.3.3 Academic & Research Institutes

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Microphysiological System Market Perspective (2020-2031)

2.2 Global Market Size by Region: 2020 VS 2024 VS 2031

2.3 Global Microphysiological System Revenue Market Share by Region (2020-2025)

2.4 Global Microphysiological System Revenue Forecast by Region (2026-2031)

2.5 Major Region and Emerging Market Analysis

2.5.1 North America Microphysiological System Market Size and Prospective (2020-2031)

2.5.2 Europe Microphysiological System Market Size and Prospective (2020-2031)

2.5.3 China Microphysiological System Market Size and Prospective (2020-2031)

3 Breakdown Data by Type

3.1 Global Microphysiological System Historic Market Size by Type (2020-2025)

3.2 Global Microphysiological System Forecasted Market Size by Type (2026-2031)

3.3 Different Types Microphysiological System Representative Players

4 Breakdown Data by End User

4.1 Global Microphysiological System Historic Market Size by End User (2020-2025)

4.2 Global Microphysiological System Forecasted Market Size by End User (2026-2031)

4.3 New Sources of Growth in Microphysiological System Application

5 Competition Landscape by Players

5.1 Global Top Players by Revenue

5.1.1 Global Top Microphysiological System Players by Revenue (2020-2025)

5.1.2 Global Microphysiological System Revenue Market Share by Players (2020-2025)

5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

5.3 Players Covered: Ranking by Microphysiological System Revenue

5.4 Global Microphysiological System Market Concentration Analysis

5.4.1 Global Microphysiological System Market Concentration Ratio (CR5 and HHI)

5.4.2 Global Top 10 and Top 5 Companies by Microphysiological System Revenue in 2024

5.5 Global Key Players of Microphysiological System Head office and Area Served

5.6 Global Key Players of Microphysiological System, Product and Application

5.7 Global Key Players of Microphysiological System, Date of Enter into This Industry

5.8 Mergers & Acquisitions, Expansion Plans

6 Region Analysis

6.1 North America Market: Players, Segments and Downstream

6.1.1 North America Microphysiological System Revenue by Company (2020-2025)

6.1.2 North America Market Size by Type

6.1.2.1 North America Microphysiological System Market Size by Type (2020-2025)

6.1.2.2 North America Microphysiological System Market Share by Type (2020-2025)

6.1.3 North America Market Size by End User

6.1.3.1 North America Microphysiological System Market Size by End User (2020-2025)

6.1.3.2 North America Microphysiological System Market Share by End User (2020-2025)

6.1.4 North America Market Trend and Opportunities

6.2 Europe Market: Players, Segments and Downstream

6.2.1 Europe Microphysiological System Revenue by Company (2020-2025)

6.2.2 Europe Market Size by Type

6.2.2.1 Europe Microphysiological System Market Size by Type (2020-2025)

6.2.2.2 Europe Microphysiological System Market Share by Type (2020-2025)

6.2.3 Europe Market Size by End User

6.2.3.1 Europe Microphysiological System Market Size by End User (2020-2025)

6.2.3.2 Europe Microphysiological System Market Share by End User (2020-2025)

6.2.4 Europe Market Trend and Opportunities

6.3 China Market: Players, Segments and Downstream

6.3.1 China Microphysiological System Revenue by Company (2020-2025)

6.3.2 China Market Size by Type

6.3.2.1 China Microphysiological System Market Size by Type (2020-2025)

6.3.2.2 China Microphysiological System Market Share by Type (2020-2025)

6.3.3 China Market Size by End User

6.3.3.1 China Microphysiological System Market Size by End User (2020-2025)

6.3.3.2 China Microphysiological System Market Share by End User (2020-2025)

6.3.4 China Market Trend and Opportunities

7 Key Players Profiles

7.1 Emulate

7.1.1 Emulate Company Details

7.1.2 Emulate Business Overview

7.1.3 Emulate Microphysiological System Introduction

7.1.4 Emulate Revenue in Microphysiological System Business (2020-2025)

7.1.5 Emulate Recent Development

7.2 Mimetas

7.2.1 Mimetas Company Details

7.2.2 Mimetas Business Overview

7.2.3 Mimetas Microphysiological System Introduction

7.2.4 Mimetas Revenue in Microphysiological System Business (2020-2025)

7.2.5 Mimetas Recent Development

7.3 TissUse

7.3.1 TissUse Company Details

7.3.2 TissUse Business Overview

7.3.3 TissUse Microphysiological System Introduction

7.3.4 TissUse Revenue in Microphysiological System Business (2020-2025)

7.3.5 TissUse Recent Development

7.4 InSphero

7.4.1 InSphero Company Details

7.4.2 InSphero Business Overview

7.4.3 InSphero Microphysiological System Introduction

7.4.4 InSphero Revenue in Microphysiological System Business (2020-2025)

7.4.5 InSphero Recent Development

7.5 Hesperos

7.5.1 Hesperos Company Details

7.5.2 Hesperos Business Overview

7.5.3 Hesperos Microphysiological System Introduction

7.5.4 Hesperos Revenue in Microphysiological System Business (2020-2025)

7.5.5 Hesperos Recent Development

7.6 CN Bio

7.6.1 CN Bio Company Details

7.6.2 CN Bio Business Overview

7.6.3 CN Bio Microphysiological System Introduction

7.6.4 CN Bio Revenue in Microphysiological System Business (2020-2025)

7.6.5 CN Bio Recent Development

7.7 TNO

7.7.1 TNO Company Details

7.7.2 TNO Business Overview

7.7.3 TNO Microphysiological System Introduction

7.7.4 TNO Revenue in Microphysiological System Business (2020-2025)

7.7.5 TNO Recent Development

7.8 28bio

7.8.1 28bio Company Details

7.8.2 28bio Business Overview

7.8.3 28bio Microphysiological System Introduction

7.8.4 28bio Revenue in Microphysiological System Business (2020-2025)

7.8.5 28bio Recent Development

7.9 Beijing Daxiang Biotech

7.9.1 Beijing Daxiang Biotech Company Details

7.9.2 Beijing Daxiang Biotech Business Overview

7.9.3 Beijing Daxiang Biotech Microphysiological System Introduction

7.9.4 Beijing Daxiang Biotech Revenue in Microphysiological System Business (2020-2025)

7.9.5 Beijing Daxiang Biotech Recent Development

7.10 Newcells Biotech

7.10.1 Newcells Biotech Company Details

7.10.2 Newcells Biotech Business Overview

7.10.3 Newcells Biotech Microphysiological System Introduction

7.10.4 Newcells Biotech Revenue in Microphysiological System Business (2020-2025)

7.10.5 Newcells Biotech Recent Development

7.11 Nortis (Quris-Al)

7.11.1 Nortis (Quris-Al) Company Details

7.11.2 Nortis (Quris-Al) Business Overview

7.11.3 Nortis (Quris-Al) Microphysiological System Introduction

7.11.4 Nortis (Quris-Al) Revenue in Microphysiological System Business (2020-2025)

7.11.5 Nortis (Quris-Al) Recent Development

7.12 Valo Health (TARA Biosystems)

7.12.1 Valo Health (TARA Biosystems) Company Details

7.12.2 Valo Health (TARA Biosystems) Business Overview

7.12.3 Valo Health (TARA Biosystems) Microphysiological System Introduction

7.12.4 Valo Health (TARA Biosystems) Revenue in Microphysiological System Business (2020-2025)

7.12.5 Valo Health (TARA Biosystems) Recent Development

7.13 Altis Biosystems

7.13.1 Altis Biosystems Company Details

7.13.2 Altis Biosystems Business Overview

7.13.3 Altis Biosystems Microphysiological System Introduction

7.13.4 Altis Biosystems Revenue in Microphysiological System Business (2020-2025)

7.13.5 Altis Biosystems Recent Development

7.14 Draper Laboratory

7.14.1 Draper Laboratory Company Details

7.14.2 Draper Laboratory Business Overview

7.14.3 Draper Laboratory Microphysiological System Introduction

7.14.4 Draper Laboratory Revenue in Microphysiological System Business (2020-2025)

7.14.5 Draper Laboratory Recent Development

7.15 Netri

7.15.1 Netri Company Details

7.15.2 Netri Business Overview

7.15.3 Netri Microphysiological System Introduction

7.15.4 Netri Revenue in Microphysiological System Business (2020-2025)

7.15.5 Netri Recent Development

7.16 Bi/ond

7.16.1 Bi/ond Company Details

7.16.2 Bi/ond Business Overview

7.16.3 Bi/ond Microphysiological System Introduction

7.16.4 Bi/ond Revenue in Microphysiological System Business (2020-2025)

7.16.5 Bi/ond Recent Development

7.17 ImmuONE

7.17.1 ImmuONE Company Details

7.17.2 ImmuONE Business Overview

7.17.3 ImmuONE Microphysiological System Introduction

7.17.4 ImmuONE Revenue in Microphysiological System Business (2020-2025)

7.17.5 ImmuONE Recent Development

7.18 AlveoliX

7.18.1 AlveoliX Company Details

7.18.2 AlveoliX Business Overview

7.18.3 AlveoliX Microphysiological System Introduction

7.18.4 AlveoliX Revenue in Microphysiological System Business (2020-2025)

7.18.5 AlveoliX Recent Development

7.19 Cherry Biotech

7.19.1 Cherry Biotech Company Details

7.19.2 Cherry Biotech Business Overview

7.19.3 Cherry Biotech Microphysiological System Introduction

7.19.4 Cherry Biotech Revenue in Microphysiological System Business (2020-2025)

7.19.5 Cherry Biotech Recent Development

7.20 Ananda Devices

7.20.1 Ananda Devices Company Details

7.20.2 Ananda Devices Business Overview

7.20.3 Ananda Devices Microphysiological System Introduction

7.20.4 Ananda Devices Revenue in Microphysiological System Business (2020-2025)

7.20.5 Ananda Devices Recent Development

7.21 Obatala Sciences

7.21.1 Obatala Sciences Company Details

7.21.2 Obatala Sciences Business Overview

7.21.3 Obatala Sciences Microphysiological System Introduction

7.21.4 Obatala Sciences Revenue in Microphysiological System Business (2020-2025)

7.21.5 Obatala Sciences Recent Development

7.22 BiomimX

7.22.1 BiomimX Company Details

7.22.2 BiomimX Business Overview

7.22.3 BiomimX Microphysiological System Introduction

7.22.4 BiomimX Revenue in Microphysiological System Business (2020-2025)

7.22.5 BiomimX Recent Development

7.23 React4life

7.23.1 React4life Company Details

7.23.2 React4life Business Overview

7.23.3 React4life Microphysiological System Introduction

7.23.4 React4life Revenue in Microphysiological System Business (2020-2025)

7.23.5 React4life Recent Development

7.24 Aracari Bio

7.24.1 Aracari Bio Company Details

7.24.2 Aracari Bio Business Overview

7.24.3 Aracari Bio Microphysiological System Introduction

7.24.4 Aracari Bio Revenue in Microphysiological System Business (2020-2025)

7.24.5 Aracari Bio Recent Development

7.25 StemPharm

7.25.1 StemPharm Company Details

7.25.2 StemPharm Business Overview

7.25.3 StemPharm Microphysiological System Introduction

7.25.4 StemPharm Revenue in Microphysiological System Business (2020-2025)

7.25.5 StemPharm Recent Development

7.26 SynVivo

7.26.1 SynVivo Company Details

7.26.2 SynVivo Business Overview

7.26.3 SynVivo Microphysiological System Introduction

7.26.4 SynVivo Revenue in Microphysiological System Business (2020-2025)

7.26.5 SynVivo Recent Development

8 Microphysiological System Market Dynamics

8.1 Microphysiological System Industry Trends

8.2 Microphysiological System Market Drivers

8.3 Microphysiological System Market Challenges

8.4 Microphysiological System Market Restraints

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Global Microphysiological System Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Global Microphysiological System Market Size Growth by End User (US$ Million): 2020 VS 2024 VS 2031

Table 3. Global Market Microphysiological System Market Size (US$ Million) by Region:2020 VS 2024 VS 2031

Table 4. Global Microphysiological System Revenue (US$ Million) Market Share by Region (2020-2025)

Table 5. Global Microphysiological System Revenue Share by Region (2020-2025)

Table 6. Global Microphysiological System Revenue (US$ Million) Forecast by Region (2026-2031)

Table 7. Global Microphysiological System Revenue Share Forecast by Region (2026-2031)

Table 8. Global Microphysiological System Market Size by Type (2020-2025) & (US$ Million)

Table 9. Global Microphysiological System Revenue Market Share by Type (2020-2025)

Table 10. Global Microphysiological System Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 11. Global Microphysiological System Revenue Market Share by Type (2026-2031)

Table 12. Representative Players of Each Type

Table 13. Global Microphysiological System Market Size by End User (2020-2025) & (US$ Million)

Table 14. Global Microphysiological System Revenue Market Share by End User (2020-2025)

Table 15. Global Microphysiological System Forecasted Market Size by End User (2026-2031) & (US$ Million)

Table 16. Global Microphysiological System Revenue Market Share by End User (2026-2031)

Table 17. New Sources of Growth in Microphysiological System Application

Table 18. Global Microphysiological System Revenue by Players (2020-2025) & (US$ Million)

Table 19. Global Microphysiological System Market Share by Players (2020-2025)

Table 20. Global Top Microphysiological System Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Microphysiological System as of 2024)

Table 21. Ranking of Global Top Microphysiological System Companies by Revenue (US$ Million) in 2024

Table 22. Global 5 Largest Players Market Share by Microphysiological System Revenue (CR5 and HHI) & (2020-2025)

Table 23. Global Key Players of Microphysiological System, Headquarters and Area Served

Table 24. Global Key Players of Microphysiological System, Product and Application

Table 25. Global Key Players of Microphysiological System, Date of Enter into This Industry

Table 26. Mergers & Acquisitions, Expansion Plans

Table 27. North America Microphysiological System Revenue by Company (2020-2025) & (US$ Million)

Table 28. North America Microphysiological System Revenue Market Share by Company (2020-2025)

Table 29. North America Microphysiological System Market Size by Type (2020-2025) & (US$ Million)

Table 30. North America Microphysiological System Market Size by End User (2020-2025) & (US$ Million)

Table 31. Europe Microphysiological System Revenue by Company (2020-2025) & (US$ Million)

Table 32. Europe Microphysiological System Revenue Market Share by Company (2020-2025)

Table 33. Europe Microphysiological System Market Size by Type (2020-2025) & (US$ Million)

Table 34. Europe Microphysiological System Market Size by End User (2020-2025) & (US$ Million)

Table 35. China Microphysiological System Revenue by Company (2020-2025) & (US$ Million)

Table 36. China Microphysiological System Revenue Market Share by Company (2020-2025)

Table 37. China Microphysiological System Market Size by Type (2020-2025) & (US$ Million)

Table 38. China Microphysiological System Market Size by End User (2020-2025) & (US$ Million)

Table 39. Emulate Company Details

Table 40. Emulate Business Overview

Table 41. Emulate Microphysiological System Product

Table 42. Emulate Revenue in Microphysiological System Business (2020-2025) & (US$ Million)

Table 43. Emulate Recent Development

Table 44. Mimetas Company Details

Table 45. Mimetas Business Overview

Table 46. Mimetas Microphysiological System Product

Table 47. Mimetas Revenue in Microphysiological System Business (2020-2025) & (US$ Million)

Table 48. Mimetas Recent Development

Table 49. TissUse Company Details

Table 50. TissUse Business Overview

Table 51. TissUse Microphysiological System Product

Table 52. TissUse Revenue in Microphysiological System Business (2020-2025) & (US$ Million)

Table 53. TissUse Recent Development

Table 54. InSphero Company Details

Table 55. InSphero Business Overview

Table 56. InSphero Microphysiological System Product

Table 57. InSphero Revenue in Microphysiological System Business (2020-2025) & (US$ Million)

Table 58. InSphero Recent Development

Table 59. Hesperos Company Details

Table 60. Hesperos Business Overview

Table 61. Hesperos Microphysiological System Product

Table 62. Hesperos Revenue in Microphysiological System Business (2020-2025) & (US$ Million)

Table 63. Hesperos Recent Development

Table 64. CN Bio Company Details

Table 65. CN Bio Business Overview

Table 66. CN Bio Microphysiological System Product

Table 67. CN Bio Revenue in Microphysiological System Business (2020-2025) & (US$ Million)

Table 68. CN Bio Recent Development

Table 69. TNO Company Details

Table 70. TNO Business Overview

Table 71. TNO Microphysiological System Product

Table 72. TNO Revenue in Microphysiological System Business (2020-2025) & (US$ Million)

Table 73. TNO Recent Development

Table 74. 28bio Company Details

Table 75. 28bio Business Overview

Table 76. 28bio Microphysiological System Product

Table 77. 28bio Revenue in Microphysiological System Business (2020-2025) & (US$ Million)

Table 78. 28bio Recent Development

Table 79. Beijing Daxiang Biotech Company Details

Table 80. Beijing Daxiang Biotech Business Overview

Table 81. Beijing Daxiang Biotech Microphysiological System Product

Table 82. Beijing Daxiang Biotech Revenue in Microphysiological System Business (2020-2025) & (US$ Million)

Table 83. Beijing Daxiang Biotech Recent Development

Table 84. Newcells Biotech Company Details

Table 85. Newcells Biotech Business Overview

Table 86. Newcells Biotech Microphysiological System Product

Table 87. Newcells Biotech Revenue in Microphysiological System Business (2020-2025) & (US$ Million)

Table 88. Newcells Biotech Recent Development

Table 89. Nortis (Quris-Al) Company Details

Table 90. Nortis (Quris-Al) Business Overview

Table 91. Nortis (Quris-Al) Microphysiological System Product

Table 92. Nortis (Quris-Al) Revenue in Microphysiological System Business (2020-2025) & (US$ Million)

Table 93. Nortis (Quris-Al) Recent Development

Table 94. Valo Health (TARA Biosystems) Company Details

Table 95. Valo Health (TARA Biosystems) Business Overview

Table 96. Valo Health (TARA Biosystems) Microphysiological System Product

Table 97. Valo Health (TARA Biosystems) Revenue in Microphysiological System Business (2020-2025) & (US$ Million)

Table 98. Valo Health (TARA Biosystems) Recent Development

Table 99. Altis Biosystems Company Details

Table 100. Altis Biosystems Business Overview

Table 101. Altis Biosystems Microphysiological System Product

Table 102. Altis Biosystems Revenue in Microphysiological System Business (2020-2025) & (US$ Million)

Table 103. Altis Biosystems Recent Development

Table 104. Draper Laboratory Company Details

Table 105. Draper Laboratory Business Overview

Table 106. Draper Laboratory Microphysiological System Product

Table 107. Draper Laboratory Revenue in Microphysiological System Business (2020-2025) & (US$ Million)

Table 108. Draper Laboratory Recent Development

Table 109. Netri Company Details

Table 110. Netri Business Overview

Table 111. Netri Microphysiological System Product

Table 112. Netri Revenue in Microphysiological System Business (2020-2025) & (US$ Million)

Table 113. Netri Recent Development

Table 114. Bi/ond Company Details

Table 115. Bi/ond Business Overview

Table 116. Bi/ond Microphysiological System Product

Table 117. Bi/ond Revenue in Microphysiological System Business (2020-2025) & (US$ Million)

Table 118. Bi/ond Recent Development

Table 119. ImmuONE Company Details

Table 120. ImmuONE Business Overview

Table 121. ImmuONE Microphysiological System Product

Table 122. ImmuONE Revenue in Microphysiological System Business (2020-2025) & (US$ Million)

Table 123. ImmuONE Recent Development

Table 124. AlveoliX Company Details

Table 125. AlveoliX Business Overview

Table 126. AlveoliX Microphysiological System Product

Table 127. AlveoliX Revenue in Microphysiological System Business (2020-2025) & (US$ Million)

Table 128. AlveoliX Recent Development

Table 129. Cherry Biotech Company Details

Table 130. Cherry Biotech Business Overview

Table 131. Cherry Biotech Microphysiological System Product

Table 132. Cherry Biotech Revenue in Microphysiological System Business (2020-2025) & (US$ Million)

Table 133. Cherry Biotech Recent Development

Table 134. Ananda Devices Company Details

Table 135. Ananda Devices Business Overview

Table 136. Ananda Devices Microphysiological System Product

Table 137. Ananda Devices Revenue in Microphysiological System Business (2020-2025) & (US$ Million)

Table 138. Ananda Devices Recent Development

Table 139. Obatala Sciences Company Details

Table 140. Obatala Sciences Business Overview

Table 141. Obatala Sciences Microphysiological System Product

Table 142. Obatala Sciences Revenue in Microphysiological System Business (2020-2025) & (US$ Million)

Table 143. Obatala Sciences Recent Development

Table 144. BiomimX Company Details

Table 145. BiomimX Business Overview

Table 146. BiomimX Microphysiological System Product

Table 147. BiomimX Revenue in Microphysiological System Business (2020-2025) & (US$ Million)

Table 148. BiomimX Recent Development

Table 149. React4life Company Details

Table 150. React4life Business Overview

Table 151. React4life Microphysiological System Product

Table 152. React4life Revenue in Microphysiological System Business (2020-2025) & (US$ Million)

Table 153. React4life Recent Development

Table 154. Aracari Bio Company Details

Table 155. Aracari Bio Business Overview

Table 156. Aracari Bio Microphysiological System Product

Table 157. Aracari Bio Revenue in Microphysiological System Business (2020-2025) & (US$ Million)

Table 158. Aracari Bio Recent Development

Table 159. StemPharm Company Details

Table 160. StemPharm Business Overview

Table 161. StemPharm Microphysiological System Product

Table 162. StemPharm Revenue in Microphysiological System Business (2020-2025) & (US$ Million)

Table 163. StemPharm Recent Development

Table 164. SynVivo Company Details

Table 165. SynVivo Business Overview

Table 166. SynVivo Microphysiological System Product

Table 167. SynVivo Revenue in Microphysiological System Business (2020-2025) & (US$ Million)

Table 168. SynVivo Recent Development

Table 169. Microphysiological System Market Trends

Table 170. Microphysiological System Market Drivers

Table 171. Microphysiological System Market Challenges

Table 172. Microphysiological System Market Restraints

Table 173. Research Programs/Design for This Report

Table 174. Key Data Information from Secondary Sources

Table 175. Key Data Information from Primary Sources

List of Figures

Figure 1. Microphysiological System Product Picture

Figure 2. Global Microphysiological System Market Share by Type: 2024 VS 2031

Figure 3. Human Organ and Tissue Models Features

Figure 4. Disease Models Features

Figure 5. Non-Human Species Models Features

Figure 6. Global Microphysiological System Market Share by End User: 2024 VS 2031

Figure 7. Pharmaceutical & Biotechnology Companies

Figure 8. Academic & Research Institutes

Figure 9. Others

Figure 10. Microphysiological System Report Years Considered

Figure 11. Global Microphysiological System Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 12. Global Microphysiological System Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global Microphysiological System Revenue Market Share by Region: 2020 VS 2024

Figure 14. North America Microphysiological System Revenue (US$ Million) Growth Rate (2020-2031)

Figure 15. Europe Microphysiological System Revenue (US$ Million) Growth Rate (2020-2031)

Figure 16. China Microphysiological System Revenue (US$ Million) Growth Rate (2020-2031)

Figure 17. Global Microphysiological System Market Share by Players in 2024

Figure 18. Global Top Microphysiological System Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Microphysiological System as of 2024)

Figure 19. The Top 10 and 5 Players Market Share by Microphysiological System Revenue in 2024

Figure 20. North America Microphysiological System Market Share by Type (2020-2025)

Figure 21. North America Microphysiological System Market Share by End User (2020-2025)

Figure 22. Europe Microphysiological System Market Share by Type (2020-2025)

Figure 23. Europe Microphysiological System Market Share by End User (2020-2025)

Figure 24. China Microphysiological System Market Share by Type (2020-2025)

Figure 25. China Microphysiological System Market Share by End User (2020-2025)

Figure 26. Emulate Revenue Growth Rate in Microphysiological System Business (2020-2025)

Figure 27. Mimetas Revenue Growth Rate in Microphysiological System Business (2020-2025)

Figure 28. TissUse Revenue Growth Rate in Microphysiological System Business (2020-2025)

Figure 29. InSphero Revenue Growth Rate in Microphysiological System Business (2020-2025)

Figure 30. Hesperos Revenue Growth Rate in Microphysiological System Business (2020-2025)

Figure 31. CN Bio Revenue Growth Rate in Microphysiological System Business (2020-2025)

Figure 32. TNO Revenue Growth Rate in Microphysiological System Business (2020-2025)

Figure 33. 28bio Revenue Growth Rate in Microphysiological System Business (2020-2025)

Figure 34. Beijing Daxiang Biotech Revenue Growth Rate in Microphysiological System Business (2020-2025)

Figure 35. Newcells Biotech Revenue Growth Rate in Microphysiological System Business (2020-2025)

Figure 36. Nortis (Quris-Al) Revenue Growth Rate in Microphysiological System Business (2020-2025)

Figure 37. Valo Health (TARA Biosystems) Revenue Growth Rate in Microphysiological System Business (2020-2025)

Figure 38. Altis Biosystems Revenue Growth Rate in Microphysiological System Business (2020-2025)

Figure 39. Draper Laboratory Revenue Growth Rate in Microphysiological System Business (2020-2025)

Figure 40. Netri Revenue Growth Rate in Microphysiological System Business (2020-2025)

Figure 41. Bi/ond Revenue Growth Rate in Microphysiological System Business (2020-2025)

Figure 42. ImmuONE Revenue Growth Rate in Microphysiological System Business (2020-2025)

Figure 43. AlveoliX Revenue Growth Rate in Microphysiological System Business (2020-2025)

Figure 44. Cherry Biotech Revenue Growth Rate in Microphysiological System Business (2020-2025)

Figure 45. Ananda Devices Revenue Growth Rate in Microphysiological System Business (2020-2025)

Figure 46. Obatala Sciences Revenue Growth Rate in Microphysiological System Business (2020-2025)

Figure 47. BiomimX Revenue Growth Rate in Microphysiological System Business (2020-2025)

Figure 48. React4life Revenue Growth Rate in Microphysiological System Business (2020-2025)

Figure 49. Aracari Bio Revenue Growth Rate in Microphysiological System Business (2020-2025)

Figure 50. StemPharm Revenue Growth Rate in Microphysiological System Business (2020-2025)

Figure 51. SynVivo Revenue Growth Rate in Microphysiological System Business (2020-2025)

Figure 52. Bottom-up and Top-down Approaches for This Report

Figure 53. Data Triangulation

Figure 54. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

What was the global market size of Microphysiological System in 2031? zhanKai

The global market size of Microphysiological System in 2031 was 370 Million USD.

Which companies rank high in the global Microphysiological System market? shouQi

Which region is expected to have the highest market share? shouQi

What was the global market size of Microphysiological System in 2025? shouQi

What is the annual compound growth rate of the global Microphysiological System market size from 2025 to 2031? shouQi

Related Reports

Global Microphysiological System Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Microphysiological System market is projected to grow from US$ 250 million in 2025 to US$ 719 million by 2032, at a CAGR of 16.2% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-08-15
Pages: 183
USD 4900.00
(Single User License)
Global Microphysiological System Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Microphysiological System market size was US$ 250 million in 2025 and is forecast to reach a readjusted size of US$ 719 million by 2032 with a CAGR of 16.2% during the forecast period 2026-2032.
Published Date: 2026-08-15
Pages: 164
USD 4250.00
(Single User License)
Global Microphysiological System Market Research Report 2026
The global Microphysiological System market was valued at US$ 250 million in 2025 and is anticipated to reach US$ 719 million by 2032, at a CAGR of 16.2% from 2026 to 2032.
Published Date: 2026-08-15
Pages: 163
USD 2900.00
(Single User License)
Microphysiological System - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Microphysiological System was estimated to be worth US$ 250 million in 2025 and is projected to reach US$ 719 million, growing at a CAGR of 16.2% from 2026 to 2032.
Published Date: 2026-08-15
Pages: 175
USD 3950.00
(Single User License)
Microphysiological System- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Microphysiological System was estimated to be worth US$ 148 million in 2024 and is forecast to a readjusted size of US$ 1134 million by 2031 with a CAGR of 34.3% during the forecast period 2025-2031.
Published Date: 2025-10-14
Pages: 222
USD 3950.00
(Single User License)
Microphysiological System - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Microphysiological System was estimated to be worth US$ 126 million in 2024 and is forecast to a readjusted size of US$ 370 million by 2031 with a CAGR of 16.2% during the forecast period 2025-2031.
Published Date: 2025-10-13
Pages: 180
USD 3950.00
(Single User License)
Global Microphysiological System Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Microphysiological System market is projected to grow from US$ 126 million in 2024 to US$ 370 million by 2031, at a CAGR of 16.2% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-10-13
Pages: 177
USD 4900.00
(Single User License)
Global Microphysiological System Market Research Report 2025
The global market for Microphysiological System was valued at US$ 126 million in the year 2024 and is projected to reach a revised size of US$ 370 million by 2031, growing at a CAGR of 16.2% during the forecast period.
Published Date: 2025-10-13
Pages: 119
USD 2900.00
(Single User License)
Global and China Microphysiological System Market Report & Forecast 2024-2030
Microphysiological Systems (MPS) are in vitro models composed of cells, tissue explants, or stem-cell derived 'organoid' formations of human or animal origin. These models provide translational biochemical, electrical, and/or physiomechanical responses to represent organ and tissue function, with great potential to replace some animals used in research. According to the U.S. Food and Drug Administration (FDA), MPS model "functional features of a specific tissue or organ of human or animal origin by exposing cells to a microenvironment that mimics the physiological aspects important for their function or pathophysiological condition." These systems are being developed to better mimic some aspects of specific organ systems or combinations of organ systems to improve upon standard two-dimensional (2D) cell systems, with the goal of eventually replacing animal models being used for hazard identification, risk assessment, and disease modeling, among other uses.
Published Date: 2024-09-04
Pages: 165
USD 4350.00
(Single User License)
Microphysiological System- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Microphysiological Systems (MPS) are in vitro models composed of cells, tissue explants, or stem-cell derived 'organoid' formations of human or animal origin. These models provide translational biochemical, electrical, and/or physiomechanical responses to represent organ and tissue function, with great potential to replace some animals used in research. According to the U.S. Food and Drug Administration (FDA), MPS model "functional features of a specific tissue or organ of human or animal origin by exposing cells to a microenvironment that mimics the physiological aspects important for their function or pathophysiological condition." These systems are being developed to better mimic some aspects of specific organ systems or combinations of organ systems to improve upon standard two-dimensional (2D) cell systems, with the goal of eventually replacing animal models being used for hazard identification, risk assessment, and disease modeling, among other uses.
Published Date: 2024-09-04
Pages: 168
USD 3950.00
(Single User License)

Global Microphysiological System Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Microphysiological System market is projected to grow from US$ 250 million in 2025 to US$ 719 million by 2032, at a CAGR of 16.2% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-08-15
Pages: 183
USD 4900.00 (Single User License)
Global Microphysiological System Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Microphysiological System market size was US$ 250 million in 2025 and is forecast to reach a readjusted size of US$ 719 million by 2032 with a CAGR of 16.2% during the forecast period 2026-2032.
Published: 2026-08-15
Pages: 164
USD 4250.00 (Single User License)
Global Microphysiological System Market Research Report 2026
The global Microphysiological System market was valued at US$ 250 million in 2025 and is anticipated to reach US$ 719 million by 2032, at a CAGR of 16.2% from 2026 to 2032.
Published: 2026-08-15
Pages: 163
USD 2900.00 (Single User License)
Microphysiological System - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Microphysiological System was estimated to be worth US$ 250 million in 2025 and is projected to reach US$ 719 million, growing at a CAGR of 16.2% from 2026 to 2032.
Published: 2026-08-15
Pages: 175
USD 3950.00 (Single User License)
Microphysiological System- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Microphysiological System was estimated to be worth US$ 148 million in 2024 and is forecast to a readjusted size of US$ 1134 million by 2031 with a CAGR of 34.3% during the forecast period 2025-2031.
Published: 2025-10-14
Pages: 222
USD 3950.00 (Single User License)
Microphysiological System - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Microphysiological System was estimated to be worth US$ 126 million in 2024 and is forecast to a readjusted size of US$ 370 million by 2031 with a CAGR of 16.2% during the forecast period 2025-2031.
Published: 2025-10-13
Pages: 180
USD 3950.00 (Single User License)
Global Microphysiological System Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Microphysiological System market is projected to grow from US$ 126 million in 2024 to US$ 370 million by 2031, at a CAGR of 16.2% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-10-13
Pages: 177
USD 4900.00 (Single User License)
Global Microphysiological System Market Research Report 2025
The global market for Microphysiological System was valued at US$ 126 million in the year 2024 and is projected to reach a revised size of US$ 370 million by 2031, growing at a CAGR of 16.2% during the forecast period.
Published: 2025-10-13
Pages: 119
USD 2900.00 (Single User License)
Global and China Microphysiological System Market Report & Forecast 2024-2030
Microphysiological Systems (MPS) are in vitro models composed of cells, tissue explants, or stem-cell derived 'organoid' formations of human or animal origin. These models provide translational biochemical, electrical, and/or physiomechanical responses to represent organ and tissue function, with great potential to replace some animals used in research. According to the U.S. Food and Drug Administration (FDA), MPS model "functional features of a specific tissue or organ of human or animal origin by exposing cells to a microenvironment that mimics the physiological aspects important for their function or pathophysiological condition." These systems are being developed to better mimic some aspects of specific organ systems or combinations of organ systems to improve upon standard two-dimensional (2D) cell systems, with the goal of eventually replacing animal models being used for hazard identification, risk assessment, and disease modeling, among other uses.
Published: 2024-09-04
Pages: 165
USD 4350.00 (Single User License)
Microphysiological System- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Microphysiological Systems (MPS) are in vitro models composed of cells, tissue explants, or stem-cell derived 'organoid' formations of human or animal origin. These models provide translational biochemical, electrical, and/or physiomechanical responses to represent organ and tissue function, with great potential to replace some animals used in research. According to the U.S. Food and Drug Administration (FDA), MPS model "functional features of a specific tissue or organ of human or animal origin by exposing cells to a microenvironment that mimics the physiological aspects important for their function or pathophysiological condition." These systems are being developed to better mimic some aspects of specific organ systems or combinations of organ systems to improve upon standard two-dimensional (2D) cell systems, with the goal of eventually replacing animal models being used for hazard identification, risk assessment, and disease modeling, among other uses.
Published: 2024-09-04
Pages: 168
USD 3950.00 (Single User License)